Annual Drug Patent Expiration for MOZOBIL
Mozobil is a drug marketed by Genzyme and included in one NDA. It is available from two suppliers. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for MOZOBIL.
This drug has forty-five patent family members in twenty-seven countries.
The generic ingredient in MOZOBIL is plexafor. Two registered suppliers for this compound. Additional details are available on plerixafor’s profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published in